Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yelena Vysotski

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Pain|November 16, 2022
Reply to Montmeat et alJoshua Aviram, Shiri Procaccia, Yelena Vysotski, et al.
Communications Medicine|July 16, 2025
Machine-learning of medical cannabis chemical profiles reveals analgesia beyond placebo expectationsAdi Hatav, Yelena Vysotski, Anna Shapira, et al.
Brain Sciences|June 13, 2020
Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional StudyJoshua Aviram, Yelena Vysotski, Paula Berman, et al.
Frontiers in Pharmacology|June 7, 2021
Prolonged Medical Cannabis Treatment is Associated With Quality of Life Improvement and Reduction of Analgesic Medication Consumption in Chronic Pain PatientsJoshua Aviram, Gil M Lewitus, Yelena Vysotski, et al.
Rambam Maimonides Medical Journal|February 5, 2020
Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis PatientsJeffrey Y Hergenrather, Joshua Aviram, Yelena Vysotski, et al.
Pain|September 20, 2021
Sex differences in medical cannabis-related adverse effectsJoshua Aviram, Gil M Lewitus, Yelena Vysotski, et al.
Pharmacological Research|May 17, 2021
Specific phytocannabinoid compositions are associated with analgesic response and adverse effects in chronic pain patients treated with medical cannabisJoshua Aviram, Gil M Lewitus, Dorit Pud, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|June 7, 2022
The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology PatientsJoshua Aviram, Gil M Lewitus, Yelena Vysotski, et al.
Pharmaceuticals (Basel, Switzerland)|December 3, 2020
Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer PatientsJoshua Aviram, Gil M Lewitus, Yelena Vysotski, et al.
European Journal of Pain (London, England)|October 16, 2020
Medical cannabis treatment for chronic pain: Outcomes and prediction of responseJoshua Aviram, Dorit Pud, Tamar Gershoni, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pain|November 16, 2022
Reply to Montmeat et alJoshua Aviram, Shiri Procaccia, Yelena Vysotski, et al.
Communications Medicine|July 16, 2025
Machine-learning of medical cannabis chemical profiles reveals analgesia beyond placebo expectationsAdi Hatav, Yelena Vysotski, Anna Shapira, et al.
Brain Sciences|June 13, 2020
Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional StudyJoshua Aviram, Yelena Vysotski, Paula Berman, et al.
Frontiers in Pharmacology|June 7, 2021
Prolonged Medical Cannabis Treatment is Associated With Quality of Life Improvement and Reduction of Analgesic Medication Consumption in Chronic Pain PatientsJoshua Aviram, Gil M Lewitus, Yelena Vysotski, et al.
Rambam Maimonides Medical Journal|February 5, 2020
Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis PatientsJeffrey Y Hergenrather, Joshua Aviram, Yelena Vysotski, et al.
Pain|September 20, 2021
Sex differences in medical cannabis-related adverse effectsJoshua Aviram, Gil M Lewitus, Yelena Vysotski, et al.
Pharmacological Research|May 17, 2021
Specific phytocannabinoid compositions are associated with analgesic response and adverse effects in chronic pain patients treated with medical cannabisJoshua Aviram, Gil M Lewitus, Dorit Pud, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|June 7, 2022
The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology PatientsJoshua Aviram, Gil M Lewitus, Yelena Vysotski, et al.
Pharmaceuticals (Basel, Switzerland)|December 3, 2020
Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer PatientsJoshua Aviram, Gil M Lewitus, Yelena Vysotski, et al.
European Journal of Pain (London, England)|October 16, 2020
Medical cannabis treatment for chronic pain: Outcomes and prediction of responseJoshua Aviram, Dorit Pud, Tamar Gershoni, et al.
Pageof 1